Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

E.D. Tex.

Novartis Vaccines and Diagnostics Inc vs Wyeth et al, No. 2:08-cv-00067 (E.D. Tex. Apr. 26, 2011)

Claims Construed
Court
U.S. District Court for the Eastern District of Texas, Marshall Division
Case No.
No. 2:08-cv-00067, Dkt. No. 205
Decided
April 26, 2011
Judge
See opinion
Document
Memorandum Opinion and Order
Docket Entry
MEMORANDUM AND OPINION. The court adopts the constructions set forth in this opinion for the disputed terms of the 620 Patent. The parties are ordered that they may not refer, directly or indirectly, to each others claim construction positi…
Length
22 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Plaintiff Novartis Vaccines and Diagnostics, Inc. (“Novartis”) filed suit against Defendants Wyeth and Wyeth Pharmaceuticals, Inc. (collectively “Wyeth”) for patent infringement of U.S. Patent No. 6,228,620 ( “the „620 Patent”). Novartis has recently withdrawn its claim for patent infringement of U.S. Patent No. 6,060,447. This Memorandum Opinion and Order outlines the Court‟s claim construction for the four disputed terms in the „620 Patent. I.